TipRanks
Advertisement
Advertisement

MIRM Stock Latest News

Mirum Pharmaceuticals price target raised to $200 from $195 at H.C. Wainwright
The FlyMirum Pharmaceuticals price target raised to $200 from $195 at H.C. Wainwright
2h ago
MIRM
Mirum Pharmaceuticals announces Phase 3 EXPAND study met primary endpoint
PremiumThe Fly
Mirum Pharmaceuticals announces Phase 3 EXPAND study met primary endpoint
5h ago
MIRM
Mirum’s AZURE-2 Trial Pits Brelovitug Against Bulevirtide in High-Stakes Hepatitis D Study
PremiumCompany Announcements
Mirum’s AZURE-2 Trial Pits Brelovitug Against Bulevirtide in High-Stakes Hepatitis D Study
4d ago
MIRM
Mirum Pharmaceuticals price target raised to $155 from $135 at RBC Capital
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $155 from $135 at RBC Capital
4d ago
MIRM
Mirum Advances MRM-3379 With Completed Phase 1 ADME Study
PremiumCompany Announcements
Mirum Advances MRM-3379 With Completed Phase 1 ADME Study
5d ago
MIRM
Mirum Pharmaceuticals price target raised to $130 from $123 at Baird
PremiumThe FlyMirum Pharmaceuticals price target raised to $130 from $123 at Baird
13d ago
MIRM
Mirum Pharmaceuticals price target raised to $160 from $145 at Citi
Premium
The Fly
Mirum Pharmaceuticals price target raised to $160 from $145 at Citi
13d ago
MIRM
Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals
Premium
Ratings
Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals
14d ago
MIRM
Vir Biotechnology in favorable position following Mirum data, says Needham
PremiumThe Fly
Vir Biotechnology in favorable position following Mirum data, says Needham
14d ago
VIR
MIRM
Mirum Therapeutics Reaffirmed as Top Pick as Analyst Hikes Price Target to $195 on Strong Clinical and Regulatory Wins
PremiumRatings
Mirum Therapeutics Reaffirmed as Top Pick as Analyst Hikes Price Target to $195 on Strong Clinical and Regulatory Wins
14d ago
MIRM
Mirum Pharmaceuticals price target raised to $195 from $140 at H.C. Wainwright
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $195 from $140 at H.C. Wainwright
14d ago
MIRM
Mirum’s Brellovitug Phase 3 Success Signals Transformational Growth
PremiumCompany Announcements
Mirum’s Brellovitug Phase 3 Success Signals Transformational Growth
14d ago
8K
MIRM
Mirum Pharmaceuticals says primary endpoint met in Phase 3 AZURE-1 study
PremiumThe FlyMirum Pharmaceuticals says primary endpoint met in Phase 3 AZURE-1 study
14d ago
MIRM
Mirum Pharmaceuticals, Incyte announce FDA approval of Atebrioz
Premium
The Fly
Mirum Pharmaceuticals, Incyte announce FDA approval of Atebrioz
17d ago
INCY
MIRM
Mirum’s AZURE-3 Trial: A New Switch Strategy in Chronic Hepatitis D
Premium
Company Announcements
Mirum’s AZURE-3 Trial: A New Switch Strategy in Chronic Hepatitis D
1M ago
MIRM
Mirum Pharmaceuticals Announces New Chief Medical Officer Appointment
PremiumCompany Announcements
Mirum Pharmaceuticals Announces New Chief Medical Officer Appointment
1M ago
8K
MIRM
Mirum Pharmaceuticals appoints Myers as Chief Medical Officer
PremiumThe Fly
Mirum Pharmaceuticals appoints Myers as Chief Medical Officer
1M ago
MIRM
Mirum Pharmaceuticals Earnings Call Highlights Growth Momentum
PremiumCompany Announcements
Mirum Pharmaceuticals Earnings Call Highlights Growth Momentum
2M ago
MIRM
Mirum Reaffirmed as Top Pick on Zilurgisertib’s Differentiated FOP Profile; Ramakanth Maintains $140 Price Target
PremiumRatings
Mirum Reaffirmed as Top Pick on Zilurgisertib’s Differentiated FOP Profile; Ramakanth Maintains $140 Price Target
2M ago
MIRM
Mirum sinks after FDA recommends conducing Phase 3 study
PremiumThe FlyMirum sinks after FDA recommends conducing Phase 3 study
2M ago
MIRM
Mirum Pharmaceuticals price target lowered to $123 from $129 at Baird
Premium
The Fly
Mirum Pharmaceuticals price target lowered to $123 from $129 at Baird
2M ago
MIRM
Mirum Pharmaceuticals price target lowered to $140 from $145 at TD Cowen
Premium
The Fly
Mirum Pharmaceuticals price target lowered to $140 from $145 at TD Cowen
2M ago
MIRM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >